Patent applications are held confidential for 18 months from the initial filing (either as a provisional or a utility before they are published, so no knowing what has been filed since the beginning of the year.
Here's the latest filing from 12-13-2013
WO/2014/0938 and US2014017191, published 06/19/2014 USE OF A NOVEL SUBCUTANEOUS NEEDLE-FREE TECHNIQUE TO DELIVER TESTOSTERONE IN HYPOGONADAL MEN
Embodiments herein are directed to methods for increasing testosterone levels in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of testosterone by needle-free injection to an injection site. Some embodiments are further directed to a method of increasing testosterone levels in a subject in need thereof, by administering to the subject a pharmaceutical composition comprising a therapeutically effective amount of testosterone and a pharmaceutically acceptable carrier by needle-free injection. Some embodiments are directed to a method of minimizing fluctuations in testosterone levels in a subject diagnosed with hypogonadism, comprising serially administering to the subject a therapeutically effective amount of testosterone by needle-free injection to an injection site.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.